3/4
04:05 pm
fulc
Fulcrum Therapeutics to Participate in the Leerink Partners Global Healthcare Conference
Low
Report
Fulcrum Therapeutics to Participate in the Leerink Partners Global Healthcare Conference
2/26
08:00 am
fulc
Fulcrum Therapeutics, Inc. (NASDAQ: FULC) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
High
Report
Fulcrum Therapeutics, Inc. (NASDAQ: FULC) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
2/26
05:53 am
fulc
Fulcrum Therapeutics Full Year 2024 Earnings: EPS Misses Expectations [Yahoo! Finance]
High
Report
Fulcrum Therapeutics Full Year 2024 Earnings: EPS Misses Expectations [Yahoo! Finance]
2/25
08:04 am
fulc
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2024 [Yahoo! Finance]
Low
Report
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2024 [Yahoo! Finance]
2/25
07:00 am
fulc
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2024
Neutral
Report
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2024
2/24
01:10 pm
fulc
Fulcrum Therapeutics Q4 2024 Earnings Preview [Seeking Alpha]
Medium
Report
Fulcrum Therapeutics Q4 2024 Earnings Preview [Seeking Alpha]
2/24
12:30 pm
fulc
https://seekingalpha.com/article/4761269-avidity-biosciences-stock-looks-tempting-but-wait-interim-phase-3-data [Seeking Alpha]
Medium
Report
https://seekingalpha.com/article/4761269-avidity-biosciences-stock-looks-tempting-but-wait-interim-phase-3-data [Seeking Alpha]
2/18
04:05 pm
fulc
Fulcrum Therapeutics to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call and Webcast on Tuesday, February 25, 2025, at 8:00 a.m. ET
Low
Report
Fulcrum Therapeutics to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call and Webcast on Tuesday, February 25, 2025, at 8:00 a.m. ET
2/7
06:03 pm
fulc
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Low
Report
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
2/7
04:30 pm
fulc
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2/6
06:52 pm
fulc
Fulcrum Therapeutics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference [Yahoo! Finance]
Medium
Report
Fulcrum Therapeutics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference [Yahoo! Finance]
2/6
04:05 pm
fulc
Fulcrum Therapeutics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
Medium
Report
Fulcrum Therapeutics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
1/31
07:07 am
fulc
Thalassemia Market Research by Treatment Type, Type, Distribution Channel, and Region - Global Forecasts 2034-2034 [Yahoo! Finance]
Medium
Report
Thalassemia Market Research by Treatment Type, Type, Distribution Channel, and Region - Global Forecasts 2034-2034 [Yahoo! Finance]